Royal Agrifirm Group has reached an agreement to acquire Hamlet Protein, a global leader in speciality soy-based protein ingredients for young animal nutrition. The transaction is expected to close in the coming weeks, subject to customary conditions.
The acquisition represents a significant step in expanding Agrifirm’s Specialties business, which provides high-value nutritional solutions and technical services to the feed industry. Its portfolio includes advanced premixes, concentrates, functional feed ingredients, farm minerals and young animal nutrition concepts designed to improve animal performance, consistency and efficiency.
Hamlet Protein is widely recognised for its highly digestible soy-based ingredients that support gut health and consistent early-life performance. Its patented technology ensures reliable and consistent quality, which is essential for feed manufacturers. The company employs around 115 people and operates production facilities in Denmark and the United States, along with a sales office in China, serving customers worldwide.
Erik Visser, CEO of Hamlet Protein, said, “Joining Royal Agrifirm Group enables us to accelerate our development, expand our global reach and continue delivering high-digestibility solutions that support young animal health. This step creates exciting new opportunities for both our customers and our employees.”
Following completion of the transaction, Hamlet Protein will continue to operate under its own name as part of Royal Agrifirm Group. Both organisations will work closely to combine their capabilities and further strengthen differentiated nutritional solutions for customers across the global feed industry.
“The acquisition aligns fully with our mission. Hamlet Protein’s proven technology strengthens our ability to support customers in achieving optimal animal health and performance throughout the life cycle, driven by our shared focus on early feeding. This directly supports our purpose of contributing to a responsible food chain for future generations,” said Piet Hilarides, CEO of Royal Agrifirm Group.
Søren Johansen, Senior Partner at Altor, Hamlet Protein’s current owner, expressed confidence in the transition, noting that Agrifirm’s focus on speciality nutrition and its international presence provide a strong platform for Hamlet Protein to further scale its technology and impact.
